Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Acupuncture in Persistent Atrial Fibrillation [NA]
This entry reports a clinical trial evaluating acupuncture for persistent atrial fibrillation sponsored by Kyunghee University Medical Cente…
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial [Phase 3]
This document reports results from RELY-ABLE, a long-term, multi-center extension study of dabigatran in patients with atrial fibrillation w…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination: the ADVICE Trial [Phase 4]
Phase 4 clinical trial evaluating adenosine after pulmonary vein isolation to target dormant conduction in paroxysmal atrial fibrillation ha…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: nContactSurgical Numeris-AF Tethered Coagulation System for Treatment of Persistent & LSP AF [NA]
The clinical trial evaluating the Numeris-AF Tethered Coagulation System for persistent and long-standing persistent atrial fibrillation was…
-
CLINICAL_TRIALS research · 2014-04-03Clinical Trial Update: Safety and Efficacy Study of The Combined Ablation Procedure To Treat Longstanding Persistent Atrial Fibrillation [NA]
The clinical trial evaluating a combined ablation procedure for longstanding persistent atrial fibrillation has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-03-31FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Multaq (dronedarone) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Crucial Areas on AF Termination
A clinical trial studying endpoints for terminating atrial fibrillation has completed. The update highlights crucial areas related to AF ter…
-
CLINICAL_TRIALS withdrawal · 2014-03-20Clinical Trial Update: Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II [Phase 3]
A Phase 3 trial evaluating prolongation of the interval between prothrombin time tests in stable patients with atrial fibrillation and valvu…
-
FDA approval · 2014-03-19FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental NDA for MULTAQ (dronedarone) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin [Phase 3]
This clinical trial update reports on a Phase 3 study evaluating the LAmbre LAA closure device for atrial fibrillation patients who cannot t…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Safety Study of Tecadenoson to Treat Atrial Fibrillation [Phase 2]
Phase 2 safety study of Tecadenoson for atrial fibrillation has completed. The report notes completion of the trial, with no results summari…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)(MK-6621-045) [Phase 3]
A Phase 3b study evaluating vernakalant injection for recent-onset symptomatic atrial fibrillation has been terminated.
-
FDA approval · 2014-03-06FDA Approved: XARELTO — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for XARELTO (rivaroxaban) submitted by Janssen Pharmaceuticals, Inc. This action approves changes re…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Antithrombotic Triple Therapy in Humans [Phase 4]
A Phase 4 study evaluating antithrombotic triple therapy in patients with atrial fibrillation and acute coronary syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment
This completed trial evaluated signal transfer of atrial fibrillation data to guide treatment decisions in patients with atrial fibrillation…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: GLORIA-AF Registry Program (Phase I)
The GLORIA-AF Registry Program Phase I update from Boehringer Ingelheim in atrial fibrillation has completed, with results posted in March 2…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: The Effect of Short Term Amiodarone Treatment After Catheter Ablation for Atrial Fibrillation [NA]
A completed study evaluated the impact of short-term amiodarone treatment after catheter ablation for atrial fibrillation. The report summar…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation [Phase 3]
Phase 3 clinical trial update evaluating whether elimination of complex fractionated atrial electrograms improves outcomes in atrial fibrill…
-
CLINICAL_TRIALS research · 2014-02-25Clinical Trial Update: Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins
This entry reports a completed clinical trial assessing whether concurrent use of Warfarin and cephalosporins prolongs the international nor…
-
CLINICAL_TRIALS research · 2014-02-25Clinical Trial Update: Endovascular Function in Atrial Fibrillation (AF) Patients
This document provides an update on a clinical trial evaluating endovascular function in atrial fibrillation patients. The sponsor is Beijin…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Personalized Warfarin Dosing by Genomics and Computational Intelligence [NA]
An update on a trial evaluating personalized warfarin dosing using genomics and computational intelligence. The study was terminated and res…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Postoperative New-onset Atrial Fibrillation in Cardiac Surgery: DECS-PNAF Project [Phase 4]
Phase 4 update on postoperative new-onset atrial fibrillation in cardiac surgery (DECS-PNAF Project); the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Pharmacogenetic Dosing of Warfarin [Phase 3]
Phase 3 clinical trial evaluating pharmacogenetic dosing of warfarin has completed, assessing personalized dosing strategies. Sponsored by A…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Study Comparing Pulmonary Vein Isolation With the Cryoballoon, Radiofrequency Energy, or Both in the Treatment of Atrial Fibrillation (AF) [Phase 4]
A Phase 4 clinical trial comparing pulmonary vein isolation techniques—cryoballoon, radiofrequency energy, or both—for atrial fibrillation h…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: RENEWING HEALTH - RegioNs of Europe WorkINg Together for HEALTH [NA]
Completed clinical trial update for the RENEWING HEALTH project, with sponsor South Karelia Social and Health Care District. The update cove…